Literature DB >> 11120763

Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients.

A Grolleau1, M J Kaplan, S M Hanash, L Beretta, B Richardson.   

Abstract

Activation of peripheral blood T cells results in a rapid and substantial rise in translation rates and proliferation, but proliferation in response to mitogen stimulation is impaired in systemic lupus erythematosus (SLE). We have investigated translation rates and initiation factor activities in T cells from SLE patients in response to activating signals. Activation by PMA plus ionomycin strongly increased protein synthesis in control T cells but not in T cells from SLE patients. The rate of protein synthesis is known to be strongly dependent on the activity of two eukaryotic translation initiation factors, eIF4E and eIF2alpha. We show that following stimulation, eIF4E expression and phosphorylation increased equivalently in control and SLE T cells. Expression of eIF4E interacting proteins - eIF4G, an inducer, and 4E-BP1 and 4E-BP2, two specific repressors of eIF4E function - and the phosphorylation level of 4E-BP1, were all identical in control and SLE T cells. In contrast, the protein kinase PKR, which is responsible for the phosphorylation and consequent inhibition of eIF2alpha activity, was specifically overexpressed in activated SLE T cells, correlating with an increase in eIF2alpha phosphorylation. Therefore, high expression of PKR and subsequent eIF2alpha phosphorylation is likely responsible, at least in part, for impaired translational and proliferative responses to mitogens in T cells from SLE patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120763      PMCID: PMC381471          DOI: 10.1172/JCI9352

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  54 in total

1.  Regulation of translation initiation factor gene expression during human T cell activation.

Authors:  X Mao; J M Green; B Safer; T Lindsten; R M Frederickson; S Miyamoto; N Sonenberg; C B Thompson
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

2.  Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE.

Authors:  C Bombardier; D D Gladman; M B Urowitz; D Caron; C H Chang
Journal:  Arthritis Rheum       Date:  1992-06

3.  The interferon-induced double-stranded RNA-activated protein kinase induces apoptosis.

Authors:  S B Lee; M Esteban
Journal:  Virology       Date:  1994-03       Impact factor: 3.616

4.  Eukaryotic translation initiation factor 4G is targeted for proteolytic cleavage by caspase 3 during inhibition of translation in apoptotic cells.

Authors:  W E Marissen; R E Lloyd
Journal:  Mol Cell Biol       Date:  1998-12       Impact factor: 4.272

5.  Molecular cloning and tissue distribution of PHAS-I, an intracellular target for insulin and growth factors.

Authors:  C Hu; S Pang; X Kong; M Velleca; J C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus.

Authors:  W Emlen; J Niebur; R Kadera
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

7.  Regulation of eukaryotic translation initiation factor expression during T-cell activation.

Authors:  T R Boal; J A Chiorini; R B Cohen; S Miyamoto; R M Frederickson; N Sonenberg; B Safer
Journal:  Biochim Biophys Acta       Date:  1993-04-16

8.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.

Authors:  A Pause; G J Belsham; A C Gingras; O Donzé; T A Lin; J C Lawrence; N Sonenberg
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

9.  PHAS-I as a link between mitogen-activated protein kinase and translation initiation.

Authors:  T A Lin; X Kong; T A Haystead; A Pause; G Belsham; N Sonenberg; J C Lawrence
Journal:  Science       Date:  1994-10-28       Impact factor: 47.728

Review 10.  T- and B-cell abnormalities in systemic lupus.

Authors:  P L Cohen
Journal:  J Invest Dermatol       Date:  1993-01       Impact factor: 8.551

View more
  17 in total

1.  Genetic linkage of systemic lupus erythematosus to 13q32 in African American families with affected male members.

Authors:  Chao Xing; Courtney Gray-McGuire; Jennifer A Kelly; Phillip Garriott; Hulya Bukulmez; John B Harley; Jane M Olson
Journal:  Hum Genet       Date:  2005-09-28       Impact factor: 4.132

Review 2.  Circular RNAs in Immune Response and Viral Infection.

Authors:  Lichong Yan; Y Grace Chen
Journal:  Trends Biochem Sci       Date:  2020-09-06       Impact factor: 13.807

3.  Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.

Authors:  Gary M Kammer
Journal:  J Clin Invest       Date:  2005-04       Impact factor: 14.808

Review 4.  Expanding Roles of Noncoding RNAs in the Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yiwei Shen; Bo Qu; Nan Shen
Journal:  Curr Rheumatol Rep       Date:  2022-03-03       Impact factor: 4.592

5.  Role of PKR and Type I IFNs in viral control during primary and secondary infection.

Authors:  Yumi Nakayama; Erin H Plisch; Jeremy Sullivan; Chester Thomas; Charles J Czuprynski; Bryan R G Williams; M Suresh
Journal:  PLoS Pathog       Date:  2010-06-24       Impact factor: 6.823

Review 6.  A tale of two proteins: PACT and PKR and their roles in inflammation.

Authors:  Evelyn Chukwurah; Kenneth T Farabaugh; Bo-Jhih Guan; Parameswaran Ramakrishnan; Maria Hatzoglou
Journal:  FEBS J       Date:  2021-01-15       Impact factor: 5.622

7.  The regulation of protein synthesis and translation factors by CD3 and CD28 in human primary T lymphocytes.

Authors:  Miranda Kleijn; Christopher G Proud
Journal:  BMC Biochem       Date:  2002-05-17       Impact factor: 4.059

Review 8.  The pathology of T cells in systemic lupus erythematosus.

Authors:  Anselm Mak; Nien Yee Kow
Journal:  J Immunol Res       Date:  2014-04-23       Impact factor: 4.818

9.  C/EBPβ-LAP*/LAP Expression Is Mediated by RSK/eIF4B-Dependent Signalling and Boosted by Increased Protein Stability in Models of Monocytic Differentiation.

Authors:  René Huber; Thomas Panterodt; Bastian Welz; Martin Christmann; Judith Friesenhagen; Andreas Westphal; Daniel Pietsch; Korbinian Brand
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

10.  PKR mediated regulation of inflammation and IL-10 during viral encephalomyelitis.

Authors:  Parul Kapil; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Neuroimmunol       Date:  2014-03-04       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.